{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=cGVHD&page=37", "query": { "condition": "cGVHD", "page": 37 }, "page_size": 10 }, "pagination": { "page": 37, "page_size": 10, "total_count": 13479, "total_pages": 1348, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=cGVHD&page=38&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=cGVHD&page=36&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-26T13:53:42.281Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05633407", "title": "Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postural Orthostatic Tachycardia Syndrome" ], "interventions": [ { "name": "Efgartigimod", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "argenx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 53, "start_date": "2022-09-23", "completion_date": "2024-04-18", "has_results": true, "last_update_posted_date": "2025-05-23", "last_synced_at": "2026-10-26T13:53:42.281Z", "location_count": 11, "location_summary": "La Jolla, California • Palo Alto, California • Glenview, Illinois + 8 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Glenview", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05633407" }, { "nct_id": "NCT00507234", "title": "Study in Subjects Greater Than 40 Years of Age With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "formoterol fumarate inhalation solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dey", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 128, "start_date": "2007-03", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2010-11-11", "last_synced_at": "2026-10-26T13:53:42.281Z", "location_count": 19, "location_summary": "Mobile, Alabama • Phoenix, Arizona • DeLand, Florida + 16 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "DeLand", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Livonia", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00507234" }, { "nct_id": "NCT04503109", "title": "Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain, Chronic", "Pain, Intractable", "Pain, Back" ], "interventions": [ { "name": "Nalu Neurostimulation System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Nalu Medical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 110, "start_date": "2020-07-16", "completion_date": "2022-09-13", "has_results": false, "last_update_posted_date": "2023-02-15", "last_synced_at": "2026-10-26T13:53:42.281Z", "location_count": 8, "location_summary": "Larkspur, California • Walnut Creek, California • Washington D.C., District of Columbia + 5 more", "locations": [ { "city": "Larkspur", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Port Charlotte", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04503109" }, { "nct_id": "NCT02525263", "title": "Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Kidney Disease", "Type 2 Diabetes" ], "interventions": [ { "name": "Neo-Kidney Augment", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Prokidney", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "30 Years to 70 Years" }, "enrollment_count": 1, "start_date": "2016-07", "completion_date": "2017-08", "has_results": true, "last_update_posted_date": "2021-04-23", "last_synced_at": "2026-10-26T13:53:42.281Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02525263" }, { "nct_id": "NCT01113593", "title": "A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "Formoterol Fumarate", "type": "DRUG" }, { "name": "Foradil Aerolizer", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dey", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 45, "start_date": "2010-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-05-27", "last_synced_at": "2026-10-26T13:53:42.281Z", "location_count": 4, "location_summary": "Clearwater, Florida • DeLand, Florida • Greenville, South Carolina + 1 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "DeLand", "state": "Florida" }, { "city": "Greenville", "state": "South Carolina" }, { "city": "Spartanburg", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01113593" }, { "nct_id": "NCT00909584", "title": "Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Severe Chronic Neutropenia" ], "interventions": [ { "name": "Ezatiostat Hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Telik", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2009-04", "completion_date": "2013-05", "has_results": false, "last_update_posted_date": "2013-11-25", "last_synced_at": "2026-10-26T13:53:42.281Z", "location_count": 4, "location_summary": "Bethesda, Maryland • Ann Arbor, Michigan • San Antonio, Texas + 1 more", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00909584" }, { "nct_id": "NCT00357084", "title": "Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "methotrexate", "type": "DRUG" }, { "name": "methylprednisolone", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 53, "start_date": "2006-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2010-09-14", "last_synced_at": "2026-10-26T13:53:42.281Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00357084" }, { "nct_id": "NCT03721952", "title": "Facilitating Communication Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Disease", "Neoplasm Metastasis", "Lung Neoplasm", "Pulmonary Disease, Chronic Obstructive", "Heart Failure, Congestive", "Liver Cirrhosis", "Kidney Failure, Chronic", "Multiple Organ Failure", "Health Care Quality, Access, and Evaluation", "Intensive Care Units", "Palliative Care, Health Services", "Palliative Care, Patient Care", "Lung Diseases", "Cerebrovascular Disorders", "Brain Injuries" ], "interventions": [ { "name": "Facilitator-Based Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 977, "start_date": "2019-04-17", "completion_date": "2024-06-30", "has_results": true, "last_update_posted_date": "2025-02-07", "last_synced_at": "2026-10-26T13:53:42.281Z", "location_count": 3, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03721952" }, { "nct_id": "NCT04967352", "title": "Predicting Chronic Pain Following Breast Surgery", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Pain", "Opioid Use", "Breast Pain", "Breast Cancer" ], "interventions": [], "intervention_types": [], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2021-07-19", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2023-07-27", "last_synced_at": "2026-10-26T13:53:42.281Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04967352" }, { "nct_id": "NCT00994162", "title": "Evaluation of the Use of EZCare/V1STA in the Management of Acute and Chronic Wounds", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Wounds" ], "interventions": [ { "name": "EZCare/V1STA Negative Pressure Wound Therapy System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Smith & Nephew, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 153, "start_date": "2008-04", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2022-09-21", "last_synced_at": "2026-10-26T13:53:42.281Z", "location_count": 1, "location_summary": "Worcester, Massachusetts", "locations": [ { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00994162" } ] }